Article
Impact of CYP2C19 polymorphism in prognosis of minor stroke or TIA patients with declined eGFR on dual antiplatelet therapy: CHANCE substudy.
The pharmacogenomics journal - 1 Dec 2018
Wu Yu, Zhou Yilun, Pan Yuesong, Zhao Xingquan, Liu Liping, Wang David, Wang Chunxue, Li Hao, Johnston S Claiborne, Meng Xia, Wang Yilong, Wang Yongjun
Abstract excerpt
Clopidogrel resistance is prevalent in chronic kidney disease (CKD) patients. Genetic polymorphism is considered to be the most important factor that influences clopidogrel resistance. Limited data exist as to the role of pharmacogenetics in prognosis of stroke patients with impaired renal function on clopidogrel. We sought to explore whether decreased kidney function alters the association between CYP2C19...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
